Takehide Murataa,*, Jianzhi Pana (c), Megumi Hirosea, Kumiko Inabea, Yukari Kujimea, Chitose Kuriharaa, Yuka Kusaa, Satoko Masuzakia, Koji Nakadea, Yuri Nakanoa, Masato Ohkuboa, Takahito Yamasakia, Yuichi Obatab, Kazunari K. Yokoyamaa (d)
The W. M. Keck Center for Innovative Cancer Therapies program at M. D. Anderson has assembled over 60 scientists and clinicians with an interest in sharing research ideas and findings worldwide. We all share the common goal of curing cancer.
The Center for Gene Therapy at the University of Michigan Medical Center was created to link basic science, clinical investigation and technology transfer. The Center fosters a multidisciplinary approach to new research as well as collaborative research endeavors in the area of gene therapy; extends the services of existing and newly created research cores to investigators; and serves as a resource for information and education.
The mandate of the Centre for Gene Therapeutics is to investigate the basic pathobiology of inflammatory, infectious and immune diseases. Procedures are then developed for the therapeutic application of genetic information for intervention in cancer immunotherapy, chronic infectious diseases and chronic disorders of the gastrointestinal, genitourinary and respiratory tracts.
The Goldyne Savad Institute of Gene Therapy has successfully recruited topnotch scientists with high scientific achievements, each of whom is afforded full scientific independence and is responsible for the development of her/his research. Cross-fertilization of ideas among these scientists not only at the Institute but with scientists from other institutions and disciplines has culminated into important scientific activities.
C/EBPa in growth arrest, differentiation and cancer
Roberts Biosolutions Ltd
Hillcoat Place, Edinburgh
United Kingdom
Email: info@genetherapyreview.com
Twitter: @gentherev
